Table 5.
Sensitivity to the Elicited Prior
| Scenario (T:Tamoxifen, P:Placebo) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| vT = 5, vP= 5 | vT = 0.2, vP= 0.2 | uT = 0.5, uP= 0.5 | uT = −0.5, uP= −0.5 | ||||||
| Treatment | Percentile | 10% | 25% | 10% | 25% | 10% | 25% | 10% | 25% |
| Tamoxifen | Minimum | 0.79 | 0.50 | 1.18 | 1.46 | 1.60 | 1.80 | 0.60 | 0.80 |
| Median | 1.20 | 1.50 | 1.20 | 1.50 | 1.70 | 2.00 | 0.70 | 1.00 | |
| Maximum | 1.70 | 2.00 | 1.22 | 1.52 | 1.80 | 2.10 | 0.80 | 1.10 | |
| P [Y7 = 1](95% CI) | 0.125(0.114, 0.136) | 0.125(0.114, 0.136) | 0.132(0.120, 0.143) | 0.117(0.107, 0.128) | |||||
| Placebo | Minimum | 0.85 | 0.80 | 1.04 | 1.28 | 1.51 | 1.70 | 0.51 | 0.70 |
| Median | 1.05 | 1.30 | 1.05 | 1.30 | 1.55 | 1.80 | 0.55 | 0.80 | |
| Maximum | 1.30 | 1.80 | 1.06 | 1.32 | 1.60 | 1.90 | 0.60 | 0.90 | |
| P [Y7 = 1](95% CI) | 0.133(0.122, 0.144) | 0.133(0.122, 0.144) | 0.139(0.128, 0.150) | 0.125(0.114, 0.135) | |||||
| Difference of P [Y7 = 1](95% CI) | −0.008(−0.024, 0.008) | −0.007(−0.023, 0.008) | −0.007(−0.023, 0.009) | −0.008(−0.023, 0.007) | |||||